lung cancer patients cohort

Aliases

cancer patients

No related entities found.

Mentioned in (37)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
• Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond. (2025)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. (2024)
• Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. (2023)
• Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. (2023)
• Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer. (2022)
• At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
• Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
• Application of third-generation sequencing in cancer research. (2021)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• Accurate detection of circulating tumor DNA using nanopore consensus sequencing. (2021)
• Best practices for variant calling in clinical sequencing. (2020)
• Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
• Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. (2020)
• Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
• Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. (2018)
• Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• An open access pilot freely sharing cancer genomic data from participants in Texas. (2016)
• Integrated digital error suppression for improved detection of circulating tumor DNA. (2016)
• Fragment Length of Circulating Tumor DNA. (2016)
• A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
• A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation. (2014)
• Fusion genes and their discovery using high throughput sequencing. (2013)
• High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
• 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.